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 Abstract    
Introduction: There are structural and functional links between autonomic nervous and endocrine systems. 
Derivatives of estrogens and gestagens applied in combined oral contraceptives (COC) reduce the production of 
endogenous sex steroids, but their eﬀect on autonomic nervous system remains unknown.
Aim: To compare indices of heart rate variability (HRV) and baroreﬂex sensitivity (BRS) among young healthy 
women taking vs. non-taking COC.
Material and methods: We performed a cross-sectional study in a group of 53 healthy women (age: 23±3 years, 
BMI: 22.3±2.8 kg/m2) taking COC for ≥ 3 months (COC-group) and in a group of 113 healthy women (age: 24±4 
years, BMI: 22.0±3.1 kg/m2) not taking COC for ≥3 months (n-COC-group). All examined women were between the 
4th and the 8th day of menstrual (or pill-driven) cycle lasting from 21 to 35 days. Indices of autonomic balance was 
assessed based on the time- and frequency- domains of heart rate variability (HRV, very low (VLF), low (LF), high 
(HF) frequencies and total HRV spectrum). BRS was evaluated using the sequence (BRS-Seq) and the controlled 
breathing (BRS-CtBr) methods.
Results: There were no diﬀerences in: age, weight, height, measures of adiposity and fat distribution, the menstrual 
(or pill-driven) cycle day on the day of examination, heart rate and HRV parameters between the two studied groups 
(all p>0.1). BRS-CtBr was higher among n-COC-group as compared to COC-group (20.00±6.28 vs. 18.07±6.57 
ms/mmHg, p<0.05). There was a trend towards higher BRS-Seq in the n-COC-group as compared to the COC-
group (19.47±7.85 vs. 16.95±5.76 ms/mmHg, p=0.12). In the n-COC-group, BRS-CtBr and RMSSD were inversely 
related to age (r=-0.23, r=-0.19, p<0.05). In the COC-group, SDNN was inversely related to waist circumference 
and WHR (respectively r=-0.34 and r=-0.35, both p<0.05).
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Introduction
?or?onal ?uctuation occurrin? ?urin? t?e ??ysiolo?ical 
?enstrual cycle ?as an e??ect on autono?ic ner?ous syste? 
acti?ity o? wo?en ?1???. ?or instance, ?arore?e? sensiti?ity 
????? is ?i??er in t?e secon? ?luteal? ??ase o? t?e cycle, ?ro?a?ly 
?ue to an ele?ate? le?el o? natural estro?ens an? ?ro?esterone ?1, 
??. 
?o??ine? oral contrace?ti?es ????? contain ?eri?ati?es 
of estrogens and gestagens, and markedly reduce the natural 
?roduction of endogenous se? hormones due to e.g. the 
interference with the regular cyclic hormone acti?ity of the 
hy?othalamic??ituitary?gonadal a?is ?????. ?sing ??? leads to 
the constant lowering of se? hormones ?lood concentration as 
com?ared to the ?hysiological le?el, ty?ical for the luteal ?hase 
???11?. ?aking into consideration close links ?etween steroid 
hormones and the functioning of autonomic system ?1??1??, we 
ha?e ?resumed that ??? might affect the functioning of A??. 
?ndices of heart rate ?aria?ility ????? and ??? are ?hysiological 
measures re?ecting the ef?ciency of re?e? regulatory mechanisms 
within cardio?ascular system ?1?, 1??.
?herefore, the aim of the ?resent study was to com?are ??? 
and ??? among young healthy women taking and non?taking 
???.
Methods
????????????????????
?he study was ?erformed in ?ardiology De?artment, 
Military ?os?ital ?Wroclaw, ?oland?. 
?he criteria for the inclusion of the study com?rised? 
1? age ?etween 1? and ?? years, 
 Conclusions: COC impair the reﬂex regulation of cardiovascular system based on baroreﬂex, which may indicate 
unfavorable inﬂuence of COC use on women`health. The exact mechanism of BRS impairment caused by COC 
remains unknown, also in the context of the diﬀerent composition of various COC. Thus, it needs to be studied 
further.
  Key words: ?????????????????????????????/ ????????? ??????? ?????? / ?????????????? 
          ????? ?????????? / ????????? ??????????? / ????? ???? ??????????? /
 Streszczenie
Wstęp: Autonomiczny układ nerwowy łączy się z układem endokrynnym zarówno strukturalnie jak i funkcjonalnie. 
Syntetyczne pochodne androgenów i gestagenów zawarte w doustnych środkach antykoncepcyjnych (COC) 
zmniejszają produkcję endogennych steroidów płciowych. Wpływ COC na układ autonomiczny pozostaje nieznany.
Cel: Celem badania było porównanie zmienności rytmu serca (HRV) i wrażliwości baroreceptorów tętniczych (BRS) 
wśród młodych, zdrowych kobiet przyjmujących vs. nieprzyjmujących COC.
Materiał i metody: Zbadano 53 zdrowe kobiety (wiek: 23±3 lata, BMI: 22,3±2,8 kg/m2) przyjmujące COC 
≥3 miesiące (grupa-COC) oraz 113 zdrowych kobiet (wiek: 24±4 lata, BMI: 22,0±3,1 kg/m2) nieprzyjmujących 
COC od ≥3 miesięcy (grupa-n-COC). Wszystkie badane kobiety były między 4. a 8. dniem cyklu, który trwał nie 
krócej niż 21 dni oraz nie dłużej niż 35 dni. Zbadano następujące wskaźniki równowagi autonomicznej: czasowe i 
częstotliwościowe domeny zmienności rytmu serca (w trzech zakresach częstotliwości: bardzo niskiej VLF, niskiej 
LF i wysokiej HF). BRS oceniano metodami: sekwencyjną (BRS-Seq) i kontrolowanego oddychania (BRS-CtBr).
Wyniki: Badane kobiety nie różniły się wiekiem, wzrostem, masą ciała czy wskaźnikami dystrybucji tkanki 
tłuszczowej (wszystkie p>0,1). W obu grupach rozkład odsetków kobiet badanych w każdym z 5 dni (4, 5, 6, 7 lub 
8) był taki sam (p>0,1).
Badane grupy nie różniły się także pod względem parametrów HRV (wszystkie p>0,1). Wartość BRS-CtBr była 
wyższa wśród kobiet z grupy n-COC w porównaniu z kobietami przyjmującymi środki hormonalne (20,00±6,28 vs. 
18,07±6,57 ms/mmHg, p<0,05). Podobny trend zaobserwowano w przypadku BRS-Seq (kobiety z grupy n-COC 
19,47±7,85 vs. kobiety z grupy COC 16,95±5,76 ms/mmHg, p=0,12). Ponadto w grupie n-COC, BRS-CtBr oraz 
RMSSD były odwrotnie proporcjonalne do wieku badanych kobiet (odpowiednio r=-0,23, r=-0,19, oba p<0,05). 
W grupie COC, SDNN było odwrotnie proporcjonalne do obwodu talii oraz wskaźnika WHR (odpowiednio r=-0,34 
i r=-0,35, oba p<0,05).
Wnioski: COC upośledza regulację układu sercowo-naczyniowego, opartą na odruchu z baroreceptorów 
tętniczych. Może to sugerować niekorzystny wpływ stosowania COC na zdrowie kobiet. Mechanizm działania 
COC na BRS jest nieznany (również w kontekście preparatów o różnym składzie), stąd opisane zjawisko wymaga 
dalszych badań.
  Słowa kluczowe: ?????????????? ?????? ??????????????? / ???????????? ????? 
        ??????? / ????????? ????????? ?????? ???????? / 
      / ?????????? ?????????????? / ????????? ????? ????? /
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?? female se?, 
?? ?hysiological length of a menstrual cycle among 
women not taking ??? ?i.e. from ?1 to ?? days?, 
?? no e?idence of any chronic?acute disease and related 
treatment.
?he e?clusion criteria included? 
1? ?regnancy or ?reast feeding? 
2) lack of written informed consent.
?he study was a??ro?ed ?y the local ethics committee and 
was conducted in accordance with the Helsinki Declaration.
??????????????????
?artici?ants of the re?orted study were recruited among 
2?? women who simultaneously ?artici?ated in another ?ro?ect 
regarding the female ?references for male mor?hology. ?he ?ro?ect 
was ad?ertised at se?eral uni?ersities in Wroclaw ?ni?ersities, 
?ia the ?ro?ect we??site and local news?a?ers. All a??ointments 
were scheduled ?etween ? a.m. and 12 a.m., and were ?erformed 
?etween the ?th and ?th day of menstrual ?or ?ill?dri?en) cycle 
of each woman. ?he ?artici?ants were ad?ised to refrain from 
drinking coffee and smoking on the day of e?amination.
?asic anthro?ometric ?arameters ?i.e. ?ody weight ?kg?, 
?ody height ?cm?, waist and hi? circumferences ?cm?) were 
measured ?efore the ?hysiological assessments, and were used to 
calculate a ?ody mass inde? ??M?? the indi?idual?s ?ody weight 
?kg? di?ided ?y the s?uare of his?her height ?m2?) and a waist?
to?hi? ratio ?WH?? the indi?idual?s waist circumference ?cm? 
di?ided ?y his?her hi? circumference ?cm?).
?artici?ants were also asked to com?lete a short ?uestionnaire 
regarding? ?a) general health status ??) the a?erage length of their 
menstrual ?or ?ill?dri?en) cycle, and ?c) thera?y with ???.
?n total, 2?? women were ?uestioned. ?ased on the ac?uired 
data, these women were di?ided in 2 grou?s? those who did not 
take ??? for ?? months ?n?11?) and those who were taking ??? 
for ?? months ?n???). Women, who did not meet these criteria, 
were e?cluded from the further study regarding the autonomic 
status ?n???, 1?? of all ?uestioned women). ?inally, 1?? healthy 
women were enrolled in the ?ro?er study descri?ed ?elow.
?he ?ro?er recordings were ?erformed in a horizontal 
?osition and were ?receded ?y 1? minutes of resting. Afterwards, 
the digital non?in?asi?e recording of synchronized systolic ?lood 
?ressure ???) and heart rate ?H?, ??? inter?als) was ac?uired 
continuously ?????A??E?, ?M?, ?ina?res Medical ?ystems 
??, Amsterdam, ?he ?etherlands, with a sam?le fre?uency of 
2?? Hz) during ?? minutes of resting and ? minutes of ?reathing 
with a s?eed of ? ?reaths ?er minute, according to the instructions 
?resented on the com?uter?s monitor.
???? ??????????? ??????????
?or the analysis, a 1??minute fragment of an acce?ta?le 
quality was selected from the whole resting recording in order 
to calculate indices of H?? and ??? using the sequence method 
??????eq). ?n order to calculate ??? using controlled ?reathing 
method ??????t?r) a 2???second fragment of an acce?ta?le 
quality from the recording ?erformed during ?reathing with a 
s?eed of ? ?reaths ?er minute was selected.
H?? was calculated using?
? time domain measures? 
mean ?? ? mean duration of ??? inter?als ?ms)? ?D?? ? 
standard de?iation of a?erage ??? inter?als ?ms)? ?M??D ? the 
square root of the mean of the sum of the squares of differences 
?etween ad?acent ??? inter?als ?ms)? and ???A?? ? num?er of 
all ?? inter?als di?ided ?y the height of the histogram of the 
distri?ution of all ?? inter?als ?1???
? frequency domain measures? 
2 main s?ectral com?onents distinguished in H?? s?ectrum 
at? low ???)? ?.?? to ?.1? Hz, and high ?H?)? ?.1? to ?.? Hz 
frequencies and within the whole frequency s?ectrum ????.? Hz) 
?total ?ower, H??total). ?ower com?onents were e??ressed in 
a?solute ?alues ?ms2) as well as a ???H? ratio in order to descri?e 
the ?alance ?etween sym?athetic and ?arasym?athetic dri?e 
within A?? ?1?, 1??.
?alculation of ?????eq was ?ased on the selection of ? 
heart ?eats sequences with a change in systolic ?? of ?1.? mmHg 
accom?anied ?y a change in a ??? inter?al of ??.? ms, which 
occurred during the whole analyzed s?ectrum segment. ????
?eq was inter?reted as an a?eraged regression slo?e of all these 
sequences relating systolic ?? to ??? inter?als ?ms?mmHg? ?1??
22?.
?????tr?r was calculated as a ratio of the a?erage am?litude 
of ??? inter?al oscillations to the a?erage am?litude of systolic 
?? oscillations ?ms?mmHg) ?2??.
2.4 Statistical analysis
?ormality of the continuous ?aria?les distri?ution was tested 
using the Kolmogoro???mirno? test. ?ontinuous ?aria?les with a 
normal distri?ution were ?resented as means ? standard de?iation 
????D). ?ontinuous ?aria?les with a skewed distri?ution were 
log transformed which ena?led to normalize their distri?ution. 
?he inter?grou? differences for continuous ?aria?les were 
tested using the ?tudent?s t?test. ?he inter?grou? differences in 
categorized ?aria?les were analyzed using the chi?square test ??2). 
?orrelations ?etween continuous ?aria?les were assessed using a 
?earson?s correlation coef?cient.
A ?alue of ???.?? was considered statistically signi?cant.
?tatistical analysis was ?erformed using ?tatistica ?.? 
software ??tat?oft, ?ulsa, ??A).
Results
There were no differences in age, weight, height, BMI, waist 
circumference and WH?, ?etween women from the ????grou? 
as com?ared to those from the n?????grou? ?all ???.2) ?Ta?le I).
Women from the ????grou? used oral contrace?ti?es 
containing ethinylestradiol, com?ined with the following 
com?onents? etonogestrel ?in ?? of women from the ????
grou?), gestodene ?in ??), desogestrel ?in 2??), dros?irenone 
?in ???), le?onogestrel ?in ??), norgestimate ?in 1??) and 
cy?roterone ?in ??).
There were no differences in indices of H?? ?etween these 
two studied grou?s ?all ???.?) ?Ta?le II).
B????tBr was higher in women from the n?????grou? 
????.??) as com?ared to those from the ????grou?. ??igure 1). 
There was also a trend towards higher B????eq in women in a 
non?????grou? as com?ared to those from ????grou? ????.12) 
?Ta?le II).
Among women not taking ???, ?M??D and B????tBr 
were in?ersely related to age ?r???.1?, ???.??? r???.2?, ???.?2, 
res?ecti?ely). ??igure 2).
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Among women taking ???, ?D?? was in?ersely related 
to WH? ?r???.??, ???.?1) ??igure ?) and to waist circumference 
?r???.??, ???.?1). Additionally in this su?grou?, T?IA?? was 
negati?ely related to waist circumference ?r???.2?, ???.??).
There were no other relations ?etween B??, indices of H?? 
and other ?arameters analyzed se?arately in women taking ?ersus 
not?taking ??? ?all ???.2).
Discussion
The ma?or ?nding of the ?resent study was lower B?? during 
the follicular ?hase of the menstrual cycle in women taking ??? 
as com?ared to those who do not use hormonal contrace?tion. 
?e? hormones ha?e numerous effects on the cardio?ascular 
system ?12?1??. ?or instance, natural estrogens enhance ?? 
synthesis ?2?? and stimulate o?ening of the calcium?acti?ated 
?otassium channels ?2??, which ?nally leads to ?asodilatation. 
Intra?enous in?ection of estrogen results in dose?de?endent 
increase of B?? in o?ariectomized female rats ?2?, 2??. On the 
other hand, there is e?idence on the negati?e effect of natural 
and synthetic se? hormones on the ?lood coagulation ?2??2??. 
?ynthetic estrogens contained in ?O? are more than 2???fold 
more ?otent than natural ones ???. They stimulate the coagulation 
?athways ?2??, which has ?een shown also in the study on 
hormone re?lacement thera?y, where synthetic estrogens caused 
susce?ti?ility to throm?osis ????. Also, ?rogesterone included 
in ?O? has an in?uence on coagulation, howe?er the risk of 
throm?osis differs  ?etween ?arious ?re?arations ??1?. Moreo?er, 
?O? im?air endothelial function ??2? and distur? ?lood ?ow. 
Other studies re?ealed the negati?e in?uence of ?O? on 
li?id meta?olism, resulting in changes, which were similar to 
those associated with an increased risk of coronary heart disease. 
Moreo?er, this effect was related to ?oth the dose and the ty?e 
of used synthetic hormone ???,???. Howe?er, there are some 
modern ?re?arations, which  do not induce any ad?erse changes 
within the meta?olism of li?ids ????.
It is known that B?? is decreased during ?regnancy ????. The 
studies ?ased on animal model ?with female rats) showed that??
OH?dihydro?rogesterone ?? ?OH?DH?? the ma?or meta?olite of 
?rogesterone ele?ation occurring during ?regnancy), is in?ol?ed 
in this changes, due to its? in?uence on ??? ?ABA A rece?tor 
function ???????. ?regnant female rats were characterised ?y 
attenuated arterial ?arore?e? sym?athoe?citation. Howe?er, 
sym?athoinhi?itory res?onses remained maintained or e?en 
?otentiated ????. 
Table I. Clinical characteristics of healthy women non taking oral contraceptives 
(n=113) and taking oral contraceptives (n=53) .
Variables ??????????????????
?????
??????
p?
values
??????????? ?????? ?????? ????
????????????????
????????????? ?????? 28 ?
???????????????? ??????? ?????8 ????
??????????? ??????? ??????? ??2?
?????????2? 22???????? 22?????2?8 ????
WHR ???2??????? ??????????? ??2?
W?????????????????
???? ?????? ?2???? ???2
H???????????
?????????????????? ????? ???? ???8
????????????????????
??????????????????
??????????????????
??????????????8? ?
?????????2????? ?????????2????? ????
Data are presented as a mean±SD or percentage where appropriate; 
COC – combined oral contraceptives; 
BMI – body mass index; 
WHR – waist-to-hip ratio
Table II. Time and frequency domain measures of HRV and BRS in healthy women 
non taking oral contraceptives (n=113) and taking oral contraceptives (n=53) .
Variables ????????????????? ??????????
??
values
?ear???a?e?Variabili????
???i?e????ai?s
?????RR????? 8???????2 8??????? ????
????????? ??????2 ?????2? ????
R????????? ?2????? ?2????? ??8?
?R????????? 2??????? 2??????8 ??8?
?ear???a?e?Variabili????
???re?ue???????ai?s
HR????????2? ????????2?2? ??????????? ????
HR????????2? ???2????2?? ?82????2??? ???2
HR?H??????2? ??????????8 ???????22?? ????
HR???????????2?
??2?????
??2??
????8???
??2?? ????
?ar?re?e???e?si?ivi??
?R????????????H?? ??????????8? ???????????? ???2
?R?????????????H?? 2?????????28 ?8?????????? ????
Data are presented as a mean±SD; 
COC – combined oral contraceptives; HRV – heart rate variability; RR – RR interval; 
SDNN – standard deviation of average RR intervals; RMSSD – the square root of the 
mean of the sum of the squares of diﬀerences between adjacent RR intervals; 
TRIANG – number of all RR intervals divided by the histogram height distribution of 
all RR intervals; VLF – very low frequency; LF – low frequency, HF – high frequency; 
BRS-Seq – baroreﬂex sensitivity calculated using sequence method; 
BRS-CtBr – baroreﬂex sensitivity calculated using control breathing method.
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?ecent studies indicated that the occurrence of ?remenstrual 
syndrome is related to the acti?ity of ?rogesterone ?endogenous 
meta?olites in ???) and ?O? can reduce these sym?toms 
effecti?ely?????2?. While using ?O? the le?el of ?rogesterone 
is lower as com?ared to the normal ?alue???1??, and its? natural 
synthesis is inhi?ited ?????, which suggest the ?otential ?ositi?e 
effect of ?O? on A?? regulation.
We ha?e demonstrated that healthy women taking ?O? 
ha?e also reduced B??, the latter ?eing associated with 
se?eral unfa?oura?le consequences ???, ???. ?educed B?? 
is accom?anied ?y other cardio?ascular risk factors, such as 
dia?etes and dysli?idaemia ????. Im?aired B?? is a signi?cant 
?redictor of cardio?ascular disease in a general ?o?ulation ????, 
and the ?redictor of ?oor outcome in ?atients with esta?lished 
heart disease ????. There is no a?aila?le literature concerning the 
direct com?arison of B?? in women taking ?O? for ?? months 
?ersus women who do not take ?O?. Howe?er, there is e?idence 
that ?O? ha?e an acute effect on B??. ?amely, Minson et al. 
e?amined ? young ?mean age ???2 years) healthy women who 
recei?ed ?O?s during 21 days and then ?lace?o for the remaining 
? days of their cycle. B?? ?assessed using microneurogra?hy and 
test with nitro?russide and ?henyle?hrine) was lower on the days 
when ?O? was used ????.
In our cross?sectional study women from the ?O? grou? 
ha?e lower B????tBr as com?ared to those from the non??O? 
grou?, ?ut also a similar ?orderline ?attern is o?ser?ed regarding 
B????eq. It is known that ?oth of these non?in?asi?e B?? 
measures are closely related to each other ????, and corres?ond 
to in?asi?e measures ?e.g. the ?henyle?hrine method) ????. 
Howe?er, the ?hysiological inter?retation of these 2 a??lied non?
in?asi?e measures of B?? is slightly different. B????eq re?ects 
the s?ontaneous ?arallel changes in systolic B? and heart rate, 
which are rather smaller in their magnitude ????. B????trBr is 
determined during the ?arorece?tor stimulation ?y an additional 
stimulus, i.e. induced ?y slow and dee? ?reathing ????, and 
changes in systolic B? and heart rate are more ra?id and greater in 
their magnitude ??1?. B????tBr method is also characterized ?y 
the ?est re?roduci?ility among all B?? measures and the lowest 
failure rate in controls and in ?atients with heart failure ??2?.
The e?act mechanism associated with reduced B?? in 
?O? grou? is unknown and requires further studies. Howe?er, 
the inhi?ition of ?O synthesis has ?een shown to decrease B?? 
in rats ????. ?O is ?eing synthesised in the endothelium ?12? 
thus it is ?ossi?le that ?O? can affect ?O synthesis, ?y their 
negati?e effect on endothelial function ??2, ???. Howe?er, the 
e?act in?uence of ?O? on ?O ?roduction requires more detailed 
studies. 
?ecent studies showed that the se?erity of su?clinical 
coronary atherosclerosis in healthy asym?tomatic su??ects was 
related to the lower B?? ????. The negati?e effect of ?O? on 
li?id meta?olisms can also ?e res?onsi?le for lower B?? in 
?O? grou?. The throm?osis susce?ti?ility occurring during 
using ?O? can affect  B?? ?y unfa?oura?le in?uence on ?lood 
?ow. Howe?er, the data ?ro?ing this theory is una?aila?le. ?O? 
contain su?stances with ?leiotro?ic effect on the organism ???. 
?egati?e effect of ?O? on A?? cannot ?e de?nitely e?cluded, 
although lower le?el of ?rogesterone could ha?e some ?ositi?e 
effect ?????2?. 
 
Figure 1. Baroreceptor sensitivity as assessed with the controlled breathing 
methods (BRS-CtBr) for the non-COC-group and COC-groups.  
The ends of the whiskers represent one standard deviation above and below the mean, 
which is presented as the middle point of the box.
 
Figure 2. The inverse relationship between BRS-CtBr and age in the n-COC-group. 
 
Figure 3. The inverse relationship between WHR and heart rate variability 
expressed as SDNN in the COC-group.
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?tudied grou?s did not differ in H??, which is in accordance 
with ?re?ious studies ????. It was ?ro?ed that H?? is constant 
during ?oth ?hases of menstrual cycle ?1,2?. Among women 
using ?O?, those with higher ?ody weight had lower indices of 
H??.  Estrogens are ?eing synthesised within the fat tissue ???? 
and the concentration of estradiol is correlated with BMI ????. 
It has ?een shown that o?ese women taking ?O? ha?e higher 
hy?othalamic??ituitary?o?arian acti?ity ????. It can ?e suggested 
that women with higher ?ody weight in ?O? grou? ha?e higher 
se? hormones concentration than those with lower ?ody weight. 
The re?ealed in?erse relation ?etween H?? and ?oth WH? 
and waist circumferences in ?O? grou? remains unclear.  This 
can ?e linked to the a?o?e mentioned ?leiotro?ic in?uence of 
?O? on the whole organism.
B?? was in?ersely related to age within the non??O? 
grou?, which is consisted with the ?re?ious ?ndings ???, ??, ?1? 
suggesting that B?? decreases with age.
Our study indicates that ?O? thera?y im?air the control 
of cardio?ascular system ?ased on ?arore?e?, howe?er 
e?act mechanisms leading to this situation are unknown and 
require further studies. ?uch an unfa?oura?le effect of ?O? 
?es?ecially the thera?y is chronic) may lead to negati?e long?
term consequence within cardio?ascular system. ?urther studies 
regarding ?arious ?O??com?onents are needed in order to 
esta?lish which su?stances are linked to the ?articular effects 
?e.g. endocrine derangements). 
Limitations of the study:
There are some limitations of the present study that need to be acknowledged. 
Firstly, we did not measure the concentrations of sex hormones in the blood of 
studied women. Secondly, as it has been mentioned within the discussion section, 
we did not analyse the potential diﬀerences related to various COC components 
within the COC-group.  This was related mainly to low number of women within 
the COC-groups, which was the crucial limitation of the presented study. 
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Szanowni Państwo,
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napisany przez klinicystów-praktyków, którzy w sposób 
jasny i zwięzły omawiają najważniejsze zagadnienia 
z zakresu ginekologii onkologicznej. 
Zgodnie z intencją Autorów, nie jest to szeroka analiza 
naukowa, lecz zbiór praktycznych wskazówek 
jak skutecznie rozpoznawać i leczyć nowotwory 
w oparciu o nowoczesną wiedzę. 
Mamy nadzieję, że zaproponowana formuła spotka się 
z dobrym przyjęciem i okaże przydatna w kształceniu 
podyplomowym lekarzy.
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